SCHEMBL23306265

SCHEMBL23306265

C[Si](C)(C)CCOCn1ccc2c(C(=O)NC3CCS(O)(O)CC3)cc(-c3cncs3)cc21

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CD38 P28907 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23306266 0.94 CD38 (0.56) CD38
SCHEMBL23305001 0.91 CD38 (0.58) CD38
SCHEMBL23329431 0.91 CD38 (0.60) CD38
SCHEMBL23304846 0.91 CD38 (0.58) CD38
SCHEMBL23329200 0.88 CD38 (0.54) CD38
SCHEMBL23306488 0.88 CD38 (0.54) CD38
SCHEMBL23329182 0.88 CD38 (0.57) CD38
SCHEMBL23305211 0.87 CD38 (0.53) CD38
SCHEMBL23329197 0.85 CD38 (0.51) CD38
SCHEMBL23304645 0.82 CD38 (0.44) CD38

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021087087-A1 N-CYCLOHEXYL-5-(THIAZOL-5-YL)-1H-INDOLE-7-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS CD38 INHIBITORS FOR INCREASING NAD+ AND FOR THE TREATMENT OF E.G. MUSCULAR DISORDERS MITOBRIDGE INC. (US) 2021-05-06 — — WO disclosed
Send feedback